Page 24 - Delaware Business Times - DE222
P. 24
BANKING & FINANCIAL SERVICES BIOPHARMACEUTICAL
Joe Westcott
Capital One
As the leader of credit giant Capital One for the Delaware market, Joe Westcott leans on his more than
20 years of experience in the state’s banking industry. With nearly 2,000 workers in the state, Westcott manages the bank’s operations and represents its investments in the community, which include working with Delaware State University and nonprofits helping small business entrepreneurship.
ALMA MATER:
BOARDS:
Q&A:
Katherine “Katie” Wilkinson
Fulton Bank
As commercial market executive for the Delaware and Cecil County, Md., markets, Katie Wilkinson has led the growth of the Lancaster, Pa.-based Fulton Bank here. She relied on her prior experience as division manager of the former Wilmington Trust to break the bank into the local market. She’s continued to give back to the community through board service, including most prominently serving as chair of the Delaware State Chamber of Commerce from
2020 to 2022.
ALMA MATERS:
BOARDS:
Q&A:
Andrew Cottone
Adesis
A trained chemist, Andrew Cottone co-founded his company Adesis in 2005 and has grown it to a success
in the greater Wilmington area. It
both innovates chemistry solutions
for pharmaceutical clients while also producing enough material to begin manufacturing of finished products.
In 2016, Adesis became a wholly- owned subsidiary of the publicly traded Universal Display Corp., and works with the parent company on
the development of OLED, or a thin, bendable layer of organic light-emitting diodes that are the foundation for modern TV and computer screens. Outside of Adesis, Cottone has also been recognized for his advocacy behind green hydrogen production, winning the 2023 Reinventing Delaware prize from the Pete du Pont Freedom Foundation for designing an ecosystem that could put Delaware at the forefront of the industry.
Michael Fleming
Delaware BioScience Association
Michael Fleming, a biopharmaceutical industry veteran who spent 18 years with global biopharmaceutical company GlaxoSmithKline (GSK),
was appointed president of the Delaware BioScience Association in June 2020. The industry association represents 160 companies in the burgeoning industry in the First
State, hosting monthly meetings to connect members, producing reports highlighting the growth of the industry, and advocating for policy changes. He’s well-suited to the role, having started his career as Wilmington state office director for the late U.S. Sen. William V. Roth Jr. Under Fleming’s leadership Del Bio has increased its visibility through hosting the state’s first daylong conference for the industry, drawing hundreds of attendees from around the region to Wilmington.
ALMA MATERS:
BOARDS:
Q&A:
22 DELAWARE 222 | DelawareBusinessTimes.com
